ArticleJournal of perinatology : official journal of the California Perinatal Association2026
Gestational age-specific effects of antenatal corticosteroids on early physiologic vulnerability and neonatal outcomes.
Article in Journal of perinatology : official journal of the California Perinatal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate gestational age (GA)-specific associations between antenatal corticosteroid (ACS) exposure and early physiologic vulnerability and neonatal outcomes in preterm infants. STUDY
designThis retrospective cohort study used Korean Neonatal Network data and included infants born 2013-2021 with birth weight <1500 g or GA < 32 weeks. ACS exposure was categorized as complete, incomplete, or none. Multivariable logistic regression estimated adjusted odds ratios, with GA-stratified analyses and a prespecified subgroup of infants born at <25 weeks.
resultsACS exposure was associated with reduced need for advanced resuscitation at birth, reduced risk of severe intraventricular hemorrhage and decreased mortality, with the strongest associations before 32 weeks' gestation. In infants born at <25 weeks, any ACS exposure was associated with greater physiologic stability and improved survival versus no ACS exposure.
conclusionsACS exposure was associated with improved physiologic stability and survival in preterm infants, with benefits greater at lower GAs.
Identifiers
42332046What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.